MHRA gives Bristol Labs the all-clear by Eric Palmer Tuesday, June 11, 2019 Bristol Laboratories, whose partial suspension by European regulators in 2017 led to drug shortages, has had its license restored.
140 jobs in jeopardy as Recipharm plans to close plant by Eric Palmer Wednesday, December 19, 2018 The cost of making upgrades to a money-losing plant may be the breaking point for Recipharm, which is weighing its closure.
Fresenius recalls sodium chloride—News of Note Thursday, November 29, 2018 Fresenius recalls 163 lots of sodium chloride, the CEO of MHRA is leaving, plus other manufacturing news.
EMA, GSK blast BMJ’s ‘flawed’ Pandemrix safety report by Angus Liu Friday, September 28, 2018 The organizations saw the article’s method as problematic, as it relies solely on suspected adverse reactions reports received from different geographies.
U.K. uncovers data integrity issues at Bangladesh drugmaker by Eric Palmer Monday, December 11, 2017 A Bangladeshi company that would like to sell an antibiotic in the U.K. has been stopped before it started.
Pfizer snags nod for nonprescription OTC Viagra sales in U.K. by Beth Snyder Bulik Wednesday, November 29, 2017 Viagra Connect, the Pfizer OTC name for its blockbuster erectile dysfunction drug, has been approved for sale in the U.K.
